jobs.jnj.com/en/jobs/
Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Our Businesses
Explore more Johnson & Johnson sites:
Switzerland
Our Company

An End-to-End Approach to Advancing Medical Innovation

Today's Top Reads Close

Last week, Dr. William Hait, Global Head, Janssen Research & Development, and Member of the Research!America Board, published a guest blog post onResearchAmerica.org where he underscored the importance of collaborating with key stakeholders to form an end-to-end approach to enhance critically needed research.

Dr. Hait emphasized that “solving complex research challenges requires more than individual effort. It also takes the willingness and skill to bring together government, academia and the private sector.”

He noted that innovative approaches that enhance the speed of medical innovation, combined with more robust U.S. federal funding of health research and new STEM education initiatives, “form an end-to-end approach that will enhance critically needed research, fostering a new generation of R&D talent, and incentivizing development of next-generation technologies. Collectively, they will help advance medical innovation for all to benefit.”

Read the full blog post here.

Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue